# Top 50 Biotechnology Angel Investors in United Kingdom in June 2026 ## Jonathan Milner - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 30 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Health Care, Medical Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs. ## Nadav Rosenberg - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 5 - Stages: Seed, Pre-Seed, Series A - Focus: Biotechnology, Artificial Intelligence, Software Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France. ## Peder Nielsen - Type: Angel - Location: Copenhagen, Hovedstaden, Denmark - Relevant deals: 3 - Stages: Seed, Convertible Note - Focus: Biotechnology, Machine Learning Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund ## Ian Hogarth - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Software, E-Commerce, Artificial Intelligence Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge. ## Stefano Bernardi - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 3 - Stages: Seed, Pre-Seed - Focus: Software, Biotechnology, Artificial Intelligence Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech. ## DrPano Kroko Churchill - Type: Angel - Location: Seattle, Washington, United States - Relevant deals: 3 - Stages: Angel, Series A - Focus: Health Care, Therapeutics, Biotechnology Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com ## Charlie Songhurst - Type: Angel - Location: Greater Seattle Area, Washington, United States - Relevant deals: 3 - Stages: Seed, Pre-Seed - Focus: Software, Information Technology, Artificial Intelligence Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics. ## Paul Wicks - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Wellness, E-Commerce Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham. ## Jeff Dean - Type: Angel - Location: Palo Alto, California, United States - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Artificial Intelligence, Information Technology, Software Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award. ## Jude Gomila - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 3 - Stages: Seed, Pre-Seed, Angel - Focus: Software, Biotechnology, Information Technology Jude Gomila is currently CEO and Founder of the startup Golden. ## Milad Alucozai - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Biotechnology, Health Care, Medical Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University. ## Darrin Disley - Type: Angel - Location: Cambridge, Cambridgeshire, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Big Data Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge. ## Damien Lane - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: SaaS, Software, Health Care Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University. ## Ed Parkinson - Type: Angel - Relevant deals: 2 - Stages: Seed - Focus: Software, Health Care, Life Science Ed Parkinson ## Amar Shah - Type: Angel - Location: San Diego, California, United States - Relevant deals: 2 - Stages: Pre-Seed, Seed, Angel - Focus: Artificial Intelligence, Software, Health Care Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge. ## Inaki Berenguer - Type: Angel - Location: New York, New York, United States - Relevant deals: 2 - Stages: Seed, Angel, Pre-Seed - Focus: FinTech, E-Commerce, Financial Services Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics. ## Serge Chiaramonte - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: FinTech, Financial Services, Information Technology Serge Chiaramonte ## Patrick Pichette - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Artificial Intelligence, Software, Machine Learning Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford. ## Chris Mairs - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Pre-Seed, Angel - Focus: Software, FinTech, Financial Services Chris Mairs - Venture Partner @ Entrepreneurs First ## Tim Dempsey - Type: Angel - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, SaaS, Financial Services Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester. ## Aidan Gomez - Type: Angel - Location: Oxford, Arkansas, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Artificial Intelligence, Software, Information Technology Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford. ## Mark Evans - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Series A, Seed, Series C - Focus: Software, E-Commerce, Health Care Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada. ## Bradley Horowitz - Type: Angel - Location: Palo Alto, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Software, Information Technology, Artificial Intelligence Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan. ## Nadav Ben-Chanoch - Type: Angel - Location: Miami, Florida, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Software, Information Technology, Health Care Nadav Ben-Chanoch ## Jon Oringer - Type: Angel - Location: Miami, Florida, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Information Technology, Health Care Jon Oringer is the founder and chairman of Shutterstock. ## Pratima Aiyagari - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Analytics, Cyber Security, SaaS Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability. ## Ariel Poler - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Angel - Focus: Software, Social Media, Internet Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children. ## Edward Lando - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Software, Health Care, Information Technology Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School. ## Paul Forster - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Software, FinTech, Financial Services Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA. ## Mati Staniszewski - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Artificial Intelligence, Software, SaaS Mati Staniszewski is the Co-Founder of ElevenLabs. ## Hugh Grant - Type: Angel - Location: Saint Louis, Missouri, United States - Relevant deals: 2 - Stages: Seed - Focus: Biotechnology, Machine Learning Hugh Grant is President and Chief Executive Officer at Monsanto. ## Jim Mellon - Type: Angel - Relevant deals: 2 - Stages: Series A, Seed - Focus: Biotechnology, Food and Beverage, Health Care Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford. ## Gilad Engel - Type: Angel - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Hardware, Analytics, Biotechnology Gilad Engel ## Robert Kopple - Type: Angel - Location: Los Angeles, California, United States - Relevant deals: 2 - Stages: Convertible Note - Focus: FinTech, Finance, Life Science Robert Kopple ## Mark P. Stevenson - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Genetics, Health Care Life Sciences Investor & Board member | Former EVP & COO Thermo Fisher Scientific ## David Rowan - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Software, Artificial Intelligence, Information Technology David Rowan is editor of the UK edition of WIRED magazine, which won 2009 Launch of the David Rowan is Editor of the WIRED UK, the technology and trends magazine covering online brands, gadgets and the culture that surrounds them. David has reported on technology for The Times and Channel 4 News, the latter requiring him to illustrate the newiPod Video from the set of a porn shoot. He's also written for The Sunday Times and Telegraph Magazines, and edited the Guardian's on-line content. David has curated an exhibition of British creative talent at the Government's Cabinet Forum conference. He has also addressed the TEDs, and frequently contributes on Newsnight and the Today programme. He also writes a monthly column for GQ. David is in touch with many of the world's leading trend-setters and spotters. In presentations he looks at how the net is disrupting almost every sector, how apps change consumer behaviour and why 'social commerce' is killing traditional marketing. He reveals the 10 trends that will change your market in the next decade - and what you should be doing now to protect yourself. ## Sami Mikati - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Software, Life Science Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa. ## Johnathan Matlock - Type: Angel - Location: Bedford, Bedfordshire, United Kingdom - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Biotechnology, Medical, Health Care Johnathan Matlock is Co-Founder Science Angel Syndicate. ## Sarah Howell - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Post-IPO Equity - Focus: Biopharma, Education, Biotechnology Sarah Howell joined Arecor Limited as Chief Executive Officer in 2015. ## Mark Gillespie - Type: Angel - Location: Los Angeles, California, United States - Relevant deals: 1 - Stages: Seed, Series B - Focus: Music, Internet, Video Recently named as one of Billboard’s 2021 Change Agents, as well as one of the World's Greatest Managers by Music Business Worldwide, Mark Gillespie is a world-class British CEO, manager, and producer whose vision and drive have led him to build Three Six Zero into the global entertainment powerhouse that it is today. Widely recognized as oneof the industry's preeminent executives, Gillespie has been instrumental in guiding the careers of Frank Ocean and Calvin Harris, most recently closing a deal in excess of $100MM for his publishing catalogue. With offices in Los Angeles, Miami, and London, Gillespie provides the leadership necessary to ensure that Three Six Zero and its clients remain at the forefront of the music, film, television, and digital content landscapeFueled by a lifelong passion for music, Gillespie launched his career in his hometown of Birmingham, UK, where he proved to be an invaluable asset for superclub Godskitchen. Since then, he has established himself as a visionary in the entertainment industry, having worked in partnerships with Sony Music Entertainment, Jay-Z and Roc Nation, and most recently Westbrook Entertainment, whose talent roster includes Will Smith, Jada Pinkett Smith, and the entire Smith Family.A relentless pioneer and entrepreneur, Gillespie has joined forces with Pete Tong MBE to run Three Six Zero Recordings, his own in-house record label, while continuing to expand an already successful presence in film and television. Along with several other projects in the pipeline, the company's first feature film – prestige drama, VOX LUX – starring Natalie Portman and Jude Law, including an original soundtrack by Sia, was released in 2018.With a passion for innovation at the intersection of media, technology, and apparel, Gillespie has invested in companies such as Outdoor Voices, Stance, Ember Technologies, Stem Disintermedia, and Saavn. Committed to giving back and continuously fostering artistic talent, Gillespie has also remained a longtime philanthropist and advocate, sitting on both the Music Committee of Children in Conflict and the core screening panel of the Recording Academy. In his downtime, Gillespie enjoys following Manchester United and is an avid collector of modern art. ## Brad Wilson - Type: Angel - Location: Plymouth Meeting, Pennsylvania, United States - Relevant deals: 1 - Stages: Seed - Focus: Health Care, Biotechnology, Machine Learning Brad Wilson Global Product Director at GlaxoSmithKline. ## Martin Chavez - Type: Angel - Location: New York, New York, United States - Relevant deals: 1 - Stages: Series A, Seed, Private Equity - Focus: Health Care, Machine Learning, Biotechnology Marty Chavez is executive vice president and chief financial officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Firmwide Capital Committee, Firmwide Risk Committee and Steering Committee on Regulatory Reform. Marty is also a member of the Firmwide Hispanic/Latino Network and the Lesbian, Gay, Bisexual andTransgender Network.Marty first joined Goldman Sachs in 1993 in the J. Aron Currency and Commodities Division, where he was a senior energy strat until 1997. He returned to the firm as a managing director in Investment Banking Division Strats in 2005, becoming global co-head of Securities Division Strats and then global co-chief operating officer of the Equities Franchise. Prior to assuming his current role, Marty was chief information officer, responsible for the Technology Division and jointly responsible with divisional leadership for the firm’s global strategists. He was named partner in 2006.Prior to first joining the firm, Marty was co-founder and chief technology officer of Quorum Software Systems from 1989 to 1993. From 1997 to 2000, he was global head of energy derivatives at Credit Suisse Financial Products. In 2000, Marty co-founded Kiodex, Inc. and was chairman and chief executive officer until 2004.Marty serves on the Harvard Board of Overseers and is a Fellow of the New York Academy of Medicine.Marty earned a PhD in Medical Information Sciences from Stanford University in 1990, an SM in Computer Science from Harvard University in 1985, and an AB, magna cum laude, in Biochemical Sciences from Harvard College in 1985. ## Ahmed Medhat - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Information Technology, Apps, Manufacturing Ahmed Medhat - Research Scientist, Core Data Science @ Meta ## Huw Bishop - Type: Angel - Relevant deals: 1 - Stages: Angel - Focus: EdTech, Training, E-Learning Huw Bishop is an individual investor. ## Sam Harris - Type: Angel - Relevant deals: 1 - Stages: Pre-Seed - Focus: Wellness, Elder Care, Health Care Sam Harris ## Dave DeWalt - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Series C, Series A - Focus: Cyber Security, Security, Network Security David G. DeWalt is the Founder and Managing Director of Dave DeWalt. He joined AllegisCyber Capital as a Managing Director in 2017. Dave is a renowned cybersecurity executive, having taken cyber industry leader FireEye public (Chairman & CEO) and served as the CEO of both McAfee and Documentum.He is a member or leader of six boards ofdirectors, including ForgeRock, ForeScout, Phantom Cyber, and OPTIV, and serves as the Vice Chairman of Delta Airlines. Dave consults regularly with government, industry players, and the corporate Board of Directors on matters related to cybersecurity policy, technology, and strategy.He holds a B.S. in computer science from the University of Delaware. ## Peer Schatz - Type: Angel - Location: Düsseldorf, Nordrhein-Westfalen, Germany - Relevant deals: 1 - Stages: Seed - Focus: Medical, Genetics, Health Care 1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association). ## Susan Lowther - Type: Angel - Location: Cambridge, Cambridgeshire, United Kingdom - Relevant deals: 1 - Stages: Post-IPO Equity - Focus: Biopharma, Education, Biotechnology Susan joined IXICO as Chief Financial Officer in October 2014. She is an experienced Executive Director with previous Board positions including Group Chief Financial Officer of Novacyt SA and Chief Financial Officer of Lab21 prior to its acquisition by Novacyt. Susan was Chief Financial Officer of BioWisdom until its acquisition by Instem plc andFinance Director of RiboTargets Limited until its acquisition by Vernalis plc. ## Sam Fazeli - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Post-IPO Equity - Focus: Biopharma, Education, Biotechnology Sam Fazeli is the Non Executive Director at Arecor Limited. ## Silla Scheepens - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Food Processing, Food and Beverage Silla Scheepens of Future Food Fund.